Skip to content

Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies, sold ADPT on Sep 15, 2026

Data as of Oct 16

▼ SELL$32.3K1,195 shares at $27.00Susan Bobulsky Chief Commercial Officer, MRDADPT Adaptive Biotechnologies Corp
Watch ADPT
Traded
Sep 15, 2026
Disclosed
Sep 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies, sold ADPT on Sep 15, 2026TRADEDDISCLOSED
ADPTSimilar stocks (XLV — its sector index fund), rebased to ADPT's price on the disclosure day
ADPT since disclosure
−15.9%
after the sale
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund

Change in closing price from Sep 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ADPT →